Literature DB >> 2295118

Protection from ifosfamide-induced alopecia by topical thiols in young rats.

J Stekar1, P Hilgard, W Holtei, U Riemer.   

Abstract

An animal model for testing substances that might prevent alopecia induced by oxazaphosphorines has been developed. It is based on the fact that the rat pups experience virtually total hair loss following administration of oxazaphosphorines. Using this model, we showed that epicutaneous treatment with sodium thioglycollate prevented ifosfamide-induced hair loss on the treated area. These experiments indicate that prevention of oxazaphosphorine-induced alopecia in man may be achieved by topical thiols.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2295118     DOI: 10.1007/bf00684892

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  5 in total

1.  [Studies on the toxicity of nitromin; interference of cystein upon nitromin toxicity].

Authors:  M ISHIDATE; Y SAKURAI; T YOSHIDA; H SATOH; E MATUI; H IMAMURA
Journal:  Gan       Date:  1953-09

2.  Teratogenicity of cyclophosphamides in newborn rats.

Authors:  J Stekar
Journal:  Arzneimittelforschung       Date:  1973-07

Review 3.  Protection against the toxicity of alkylating agents by thiols: the mechanism of protection and its relevance to cancer chemotherapy. A review.

Authors:  T A Connors
Journal:  Eur J Cancer       Date:  1966-12       Impact factor: 9.162

4.  Effect of radioprotectors on damage induced by alkylating agents on tumoural and normal tissues.

Authors:  S Garattini; V Palma; A Guaitani
Journal:  Eur J Cancer       Date:  1966-08       Impact factor: 9.162

5.  Doxorubicin-induced hair loss in the Angora rabbit: a study of treatments to protect against the hair loss.

Authors:  G Powis; K L Kooistra
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

  5 in total
  1 in total

1.  L-cysteine prodrug protects against cyclophosphamide urotoxicity without compromising therapeutic activity.

Authors:  J C Roberts; D J Francetic; R T Zera
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.